Abstract

BackgroundThere is a lack of studies regarding the optimal timing for endoscopic retrograde cholangiopancreatography (ERCP) in patients with cholangitis caused by distal malignant biliary obstruction (MBO). This study aims to investigate the optimal timing of ERCP in patients with acute cholangitis associated with distal MBO with a naïve papilla.MethodsA total of 421 patients with acute cholangitis, associated with distal MBO, were enrolled for this study. An urgent ERCP was defined as being an ERCP performed within 24 h following emergency room (ER) arrival, and early ERCP was defined as an ERCP performed between 24 and 48 h following ER arrival. We evaluated both 30-day and 180-day mortality as primary outcomes, according to the timing of the ERCP.ResultsThe urgent ERCP group showed the lowest 30-day mortality rate (2.2%), as compared to the early and delayed ERCP groups (4.3% and 13.5%) (P < 0.001). The 180-day mortality rate was lowest in the urgent ERCP group, followed by early ERCP and delayed ERCP groups (39.4%, 44.8%, 60.8%; P = 0.006). A subgroup analysis showed that in both the primary distal MBO group, as well as in the moderate-to-severe cholangitis group, the urgent ERCP had significantly improved in both 30-day and 180-day mortality rates. However, in the secondary MBO and mild cholangitis groups, the difference in mortality rate between urgent, early, and delayed ERCP groups was not significant.ConclusionsIn patients with acute cholangitis associated with distal MBO, urgent ERCP might be helpful in improving the prognosis, especially in patients with primary distal MBO or moderate-to-severe cholangitis.

Highlights

  • There is a lack of studies regarding the optimal timing for endoscopic retrograde cholangiopancrea‐ tography (ERCP) in patients with cholangitis caused by distal malignant biliary obstruction (MBO)

  • The purpose of this study is to evaluate the outcomes according to the timing of ERCP in patients with acute cholangitis due to distal MBO

  • This study found that urgent ERCP clearly improved the 30-day mortality rate and the 180-day mortality rate, especially in patients with primary MBO and moderate-to-severe cholangitis

Read more

Summary

Introduction

There is a lack of studies regarding the optimal timing for endoscopic retrograde cholangiopancrea‐ tography (ERCP) in patients with cholangitis caused by distal malignant biliary obstruction (MBO). This study aims to investigate the optimal timing of ERCP in patients with acute cholangitis associated with distal MBO with a naïve papilla. Malignant biliary obstruction (MBO), such as pancreatic cancer, cholangiocarcinoma, or metastatic cancer, constitutes 10–30% of cholangitis cases [3, 5, 7,8,9]. Unlike patients with early-stage cancer, which can be treated curatively, the prognosis for patients with MBO caused by metastatic cancer is worse, regardless of adequate biliary drainage [17]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call